Nodal involvement in patients with small, clinically node-negative HER2-positive breast cancer after staging with FDG-PET/CT and neoadjuvant systemic therapy

Nodal involvement in patients with small, clinically node-negative HER2-positive breast cancer after staging with FDG-PET/CT and neoadjuvant systemic therapy

Background: Guidelines recommend systemic therapy for stage I HER2+ breast cancer (BC). Neoadjuvant systemic treatment (NAST) allows response-guided adjuvant treatment. However, prior to NAST only clinical nodal staging is available, risking undertreatment if ypN+ is observed. Here, we aim to evalua...

Full description

Saved in:
Bibliographic Details
Main Authors: Josefien P. van Olmen, Veerle CM. Geurts, Marie-Jeanne TFD. Vrancken Peeters, Caroline A. Drukker, Marcel PM. Stokkel, Marleen Kok, Frederieke H. van Duijnhoven
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Breast
Subjects:
Breast cancer
FDG-PET/CT
Neoadjuvant treatment
HER2 positive
Online Access:http://www.sciencedirect.com/science/article/pii/S096097762400153X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S096097762400153X

Similar Items